   3.2.1.140 | purified enzyme in complex with inhibitors 2-acetamido-2-deoxy-3-O-(beta-D-galactopyranosyl)-D-gluconohydroxyimino-1,5-lactone, 2-acetamido-3-O-(beta-D-galactopyranosyl)-1,5-imino-1,2,5-trideoxy-D-glucitol, 6-acetamido-6-deoxy-7-O-(beta-D-galactopyranosyl)castanospermine, and 8-acetamido-8-deoxy-2-O-(beta-D-galactopyranosyl)australine, sitting drop vapor diffusion method, mixing of 0.001 ml of 10 mg/ml protein solution containing 0.1 mM ligand, with an equal volume of a reservoir solution containing 0.2 M potassium sodium tartrate tetrahydrate, 0.1 M sodium citrate, pH 5.6, and 2.0 M ammonium sulfate, 20°C, X-ray diffraction structure determination and analysis at 1.6-2.2 A resolution, modeling |
| 3.2.1.140 | purified wild-type and selenomethionine-labeled enzymes in complex with Gal-beta-(1->3)-GlcNAc and Gal-beta-(1->3)-GlcNAc-thiazoline, sitting drop vapor diffusion method, mixing of 0.0005 ml of 7 mg/ml protein and 10 mM Gal-beta-(1->3)-GlcNAc with an equal volume of reservoir solution containing 0.2 M potassium sodium tartrate tetrahydrate, 0.1 M sodium citrate, pH 5.6, and 2.0 M ammonium sulfate, X-ray diffraction structure determination and analysis at 1.8 A resolution |
